A double blind, placebo and piracetam controlled, multicenter trial of vinpocetine in dementia of Alzheimer's type and vascular dementia
✍ Scribed by Wolters, E.Ch.; Scheltens, Ph.; Zwart, J.; Persijn, L.; Moll, C.; van Genuchten, H.; Löwenthal, A.; Sennef, C.
- Book ID
- 123182864
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 189 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0197-4580
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: To evaluate the efficacy and safety of low-dose risperidone in treating psychosis of alzheimer's disease (ad) and mixed dementia (md) in a subset of nursing-home residents who had dementia and aggression and who were participating in a randomized placebo-controlled trial of risperidon
Objective. To determine whether semantic memory is impaired in vascular dementia and to assess the utility of semantic memory measures in dierentiating vascular dementia from dementia of Alzheimer's type (DAT). Design. Case-control study. Patients. Ten patients with Cambridge Mental Disorders in t
The cognitive decline in Alzheimer's disease has been shown to correlate with deficits in central cholinergic neurotransmission. Among various treatment attempts using cholinergic drugs a trial of the cholinesterase inhibitor tetrahydroaminoacridine (THA) (Summers et al., 1986) attracted considerabl